Publishers

Need unique free news content for your site customized to your audience?

Let's Discuss

PRESS RELEASE
By: News Direct
July 25, 2024

This Pharma Company Is Preparing To Launch Its Lead Candidate

By Johnny Rice, Benzinga

Leonard Mazur, CEO and founder of Citius Pharmaceuticals (NASDAQ: CTXR), was recently interviewed by Benzinga.

Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, stem cell therapy, and unique prescription products.

Mazur spoke about the exciting developments in the company’s assets, including the imminent launch of its first drug on the market.

Learn more here:

Featured photo by freestocks on Unsplash.

Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders.

This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.

Contact Details

Benzinga

+1 877-440-9464

info@benzinga.com

Company Website

http://www.benzinga.com

View source version on newsdirect.com: https://newsdirect.com/news/this-pharma-company-is-preparing-to-launch-its-lead-candidate-252698575

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This press release is distributed by News Direct. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is This Pharma Company Is Preparing To Launch Its Lead Candidate.

{site_meta && site_meta.display_name} Logo

News Direct

The News Direct platform offers a unique blend of technology and customization. Dive into a world of intuitive design, featuring compelling visuals, interactive elements, and seamless navigation.